HIGHLAND CAPITAL MANAGEMENT LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$584,000
+16.6%
7,1000.0%0.03%
+9.7%
Q1 2019$501,000
+56.6%
7,1000.0%0.03%
+24.0%
Q4 2018$320,000
-37.1%
7,100
-21.1%
0.02%
-10.7%
Q3 2018$509,000
-15.3%
9,0000.0%0.03%
-17.6%
Q2 2018$601,000
+134.8%
9,000
+104.5%
0.03%
+161.5%
Q1 2018$256,000
-9.9%
4,4000.0%0.01%0.0%
Q4 2017$284,000
-9.8%
4,400
-26.7%
0.01%
-7.1%
Q3 2017$315,000
+38.8%
6,000
+23.7%
0.01%
+40.0%
Q2 2017$227,000
-5.4%
4,8500.0%0.01%
-16.7%
Q1 2017$240,0004,8500.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders